Masimo Return on Tangible Equity 2010-2024 | MASI
Current and historical return on tangible equity values for Masimo (MASI) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Masimo Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-06-30 | $0.08B | $0.65B | 13.16% |
| 2024-03-31 | $0.08B | $0.62B | 13.66% |
| 2023-12-31 | $0.08B | $0.61B | 14.41% |
| 2023-09-30 | $0.09B | $0.55B | 16.20% |
| 2023-06-30 | $0.12B | $0.56B | 21.96% |
| 2023-03-31 | $0.12B | $0.56B | 23.80% |
| 2022-12-31 | $0.14B | $0.53B | 20.30% |
| 2022-09-30 | $0.17B | $0.47B | 18.40% |
| 2022-06-30 | $0.19B | $0.43B | 16.81% |
| 2022-03-31 | $0.22B | $1.41B | 16.74% |
| 2021-12-31 | $0.23B | $1.41B | 18.06% |
| 2021-09-30 | $0.23B | $1.29B | 18.97% |
| 2021-06-30 | $0.22B | $1.21B | 18.30% |
| 2021-03-31 | $0.23B | $1.15B | 18.81% |
| 2020-12-31 | $0.24B | $1.23B | 19.72% |
| 2020-09-30 | $0.22B | $1.28B | 18.68% |
| 2020-06-30 | $0.22B | $1.21B | 19.57% |
| 2020-03-31 | $0.21B | $1.15B | 19.54% |
| 2019-12-31 | $0.20B | $1.12B | 19.02% |
| 2019-09-30 | $0.19B | $1.06B | 19.38% |
| 2019-06-30 | $0.20B | $0.99B | 21.27% |
| 2019-03-31 | $0.20B | $0.96B | 22.45% |
| 2018-12-31 | $0.19B | $0.92B | 23.72% |
| 2018-09-30 | $0.14B | $0.86B | 18.35% |
| 2018-06-30 | $0.12B | $0.78B | 16.63% |
| 2018-03-31 | $0.12B | $0.72B | 17.48% |
| 2017-12-31 | $0.13B | $0.68B | 19.30% |
| 2017-09-30 | $0.36B | $0.67B | 59.19% |
| 2017-06-30 | $0.35B | $0.66B | 68.82% |
| 2017-03-31 | $0.34B | $0.59B | 82.66% |
| 2016-12-31 | $0.31B | $0.51B | 99.13% |
| 2016-09-30 | $0.11B | $0.28B | 45.08% |
| 2016-06-30 | $0.10B | $0.25B | 44.25% |
| 2016-03-31 | $0.09B | $0.22B | 39.91% |
| 2015-12-31 | $0.08B | $0.23B | 34.55% |
| 2015-09-30 | $0.08B | $0.22B | 32.26% |
| 2015-06-30 | $0.08B | $0.24B | 30.22% |
| 2015-03-31 | $0.07B | $0.28B | 27.33% |
| 2014-12-31 | $0.07B | $0.26B | 27.44% |
| 2014-09-30 | $0.06B | $0.23B | 22.57% |
| 2014-06-30 | $0.06B | $0.27B | 22.34% |
| 2014-03-31 | $0.07B | $0.30B | 23.99% |
| 2013-12-31 | $0.06B | $0.28B | 22.92% |
| 2013-09-30 | $0.06B | $0.26B | 26.64% |
| 2013-06-30 | $0.06B | $0.24B | 25.78% |
| 2013-03-31 | $0.06B | $0.23B | 25.30% |
| 2012-12-31 | $0.06B | $0.23B | 24.56% |
| 2012-09-30 | $0.06B | $0.26B | 23.20% |
| 2012-06-30 | $0.06B | $0.28B | 23.10% |
| 2012-03-31 | $0.06B | $0.26B | 22.90% |
| 2011-12-31 | $0.06B | $0.27B | 23.99% |
| 2011-09-30 | $0.07B | $0.29B | 25.93% |
| 2011-06-30 | $0.07B | $0.27B | 27.66% |
| 2011-03-31 | $0.06B | $0.24B | 27.92% |
| 2010-12-31 | $0.07B | $0.22B | 33.49% |
| 2010-09-30 | $0.07B | $0.24B | 30.47% |
| 2010-06-30 | $0.07B | $0.22B | 28.39% |
| 2010-03-31 | $0.07B | $0.20B | 27.15% |
| 2009-12-31 | $0.05B | $0.28B | 20.85% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $6.252B | $2.048B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $234.954B | 28.16 |
| Intuitive Surgical (ISRG) | United States | $175.058B | 99.12 |
| Alcon (ALC) | Switzerland | $48.180B | 33.92 |
| IQVIA Holdings (IQV) | United States | $45.858B | 25.99 |
| Edwards Lifesciences (EW) | United States | $42.144B | 27.01 |
| IDEXX Laboratories (IDXX) | United States | $39.616B | 47.66 |
| DexCom (DXCM) | United States | $27.786B | 39.62 |
| STERIS (STE) | Ireland | $23.777B | 27.74 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.808B | 0.00 |
| Waters (WAT) | United States | $20.560B | 30.65 |
| Hologic (HOLX) | United States | $18.870B | 20.52 |
| Sysmex ADR (SSMXY) | Japan | $12.134B | 38.05 |
| Teleflex (TFX) | United States | $11.552B | 17.96 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.379B | 12.76 |
| Globus Medical (GMED) | United States | $9.844B | 27.54 |
| Penumbra (PEN) | United States | $7.859B | 81.58 |
| Glaukos (GKOS) | United States | $7.357B | 0.00 |
| TransMedics (TMDX) | United States | $5.606B | 240.09 |
| Integer Holdings (ITGR) | United States | $4.361B | 25.50 |
| PROCEPT BioRobotics (PRCT) | United States | $4.103B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.848B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.736B | 16.05 |
| Elekta AB (EKTAY) | Sweden | $2.601B | 21.19 |
| Inari Medical (NARI) | United States | $2.519B | 0.00 |
| Veracyte (VCYT) | United States | $2.423B | 150.24 |
| Nihon Kohden (NHNKY) | Japan | $2.287B | 14.23 |
| RxSight (RXST) | United States | $2.086B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.578B | 7.19 |
| OPKO Health (OPK) | United States | $1.172B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.142B | 0.00 |
| Artivion (AORT) | United States | $1.137B | 104.38 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.113B | 19.85 |
| Silk Road Medical (SILK) | United States | $1.102B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.969B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.774B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.723B | 18.26 |
| Paragon 28 (FNA) | United States | $0.695B | 0.00 |
| SiBone (SIBN) | United States | $0.693B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.666B | 0.00 |
| IRadimed (IRMD) | United States | $0.595B | 32.16 |
| AxoGen (AXGN) | United States | $0.576B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.384B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.373B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.358B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.341B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.325B | 9.92 |
| Delcath Systems (DCTH) | United States | $0.306B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.300B | 0.00 |
| Inogen (INGN) | United States | $0.291B | 0.00 |
| NeuroPace (NPCE) | United States | $0.231B | 0.00 |
| Nevro (NVRO) | United States | $0.231B | 0.00 |
| Accuray (ARAY) | United States | $0.216B | 0.00 |
| CVRx (CVRX) | United States | $0.215B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.187B | 13.09 |
| Atossa Genetics (ATOS) | United States | $0.172B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.171B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.141B | 0.00 |
| 908 Devices (MASS) | United States | $0.137B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.134B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.116B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.107B | 15.90 |
| Monogram Orthopaedics (MGRM) | United States | $0.087B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
| InspireMD (NSPR) | Israel | $0.069B | 0.00 |
| Envoy Medical (COCH) | United States | $0.059B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.058B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.056B | 0.00 |
| LENSAR (LNSR) | United States | $0.054B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.047B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.043B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.039B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.037B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| ReWalk Robotics (LFWD) | United States | $0.030B | 0.00 |
| Neuronetics (STIM) | United States | $0.027B | 0.00 |
| Spectral AI (MDAI) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.017B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.015B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.015B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.015B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |